STIGALL L. JEREMY (GM, Biologics & Drug Delivery) exercised options at CLEARPOINT NEURO, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/10/2026ACC: 0001193125-26-100353
Officer· GM, Biologics & Drug Delivery
Since May 2022
-6.91K
Net shares
Net seller
$69.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
17.78K acquired · 24.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17.78K
Price / share
—
Trade value
—
% of position
23.2%
3/6/2026
76.71K→94.48K
Common Stock
Direct
Shares
−6.91K
Price / share
$10.00
Trade value
$69.13K
% of position
7.3%
3/6/2026
94.48K→87.57K
Total
Net shares
+10.87K
Net value
-$69.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | M · Option Exercise | +17.78K | — | — | 23.2% | 76.71K | 94.48K |
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −6.91K | $10.00 | $69.13K | 7.3% | 94.48K | 87.57K |
| Total | +10.87K | -$69.13K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
17.78K shares
Shares
−17.78K
Strike price
Held after
0.00
Exercisable
—
3/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock17.78K shares | 3/6/2026 | M · Option Exercise | −17.78K | — | 0.00 |